Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuroplastin is a cell adhesion molecule encoded by the NPTN gene and a member of the immunoglobulin superfamily, present as multiple isoforms (notably np65, brain-specific, and np55, ubiquitous). It mediates cell-cell and cell-substrate interactions in the nervous system, especially at synapses. It plays critical roles in synaptic plasticity mechanisms essential for learning and memory, including long-term potentiation, and participates in neurite outgrowth and synapse maturation via signaling cascades such as the MAPK pathway and FGFR1 signaling. Neuroplastin is also a key auxiliary protein for plasma membrane calcium ATPases, regulating neuronal calcium homeostasis and modulating synaptic function. It is highly expressed in the brain, with emerging evidence for roles in cognition, neurodevelopmental and psychiatric disorders, neurodegenerative changes, and even as a molecular gatekeeper for cell energy metabolism by chaperoning monocarboxylate transporters. Although genetically and pathophysiologically linked to several diseases, neuroplastin is not currently a direct therapeutic target, and no drugs are known to modulate its function in clinical practice[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuroplastin (NPTN).